艾司洛尔与胺碘酮控制快速心房颤动心室率的效果观察

摘要

目的：比较急诊静脉注射艾司洛尔、胺碘酮控制快速房颤心室率的疗效及安全性。方法：将115例快速房颤患者随机分为两组，两组分别给予静脉注射胺碘酮和艾司洛尔治疗，比较两组治疗效果。结果：艾司洛尔组心率减慢情况显著优于胺碘酮组，差异有统计学意义(P<0.01)；艾司洛尔组平均起效时间、心室率下降幅度均显著优于胺碘酮组(P<0.01)；两组总有效率比较，差异无统计学意义(P>0.05)。结论：静脉注射艾司洛尔和胺碘酮在控制快速房颤患者心室率方面都同样安全和有效，艾司洛尔较胺碘酮能更快、更有效地控制快速房颤的心室率。%Objective:To evaluate the efficacy and safety of intravenous Esmolol and Amiodarone controlling ventricular rate in the patients with rapid atrial fibrillation.Method:115 patients with rapid atrial fibrillation patients were randomly divided into two groups,two groups were given intravenous injection of amiodarone and esmolol treatment,compared two groups of treatment effect.Result:Esmolol group heart rate was significantly higher than that of amiodarone group,the difference was statistically significant(P<0.01).Esmolol group average onset time,ventricular rate decreased significantly superior to amiodarone group(P<0.01);the two groups efficiency compared,the difference was not statistically significant(P>0.05).Conclusion:Intravenous Esmolol and Amiodarone in patients with rapid atrial fibrillation ventricular rate are equally safe and effective,Esmolol than Amiodarone can faster,more effective control of rapid atrial fibrillation ventricular rate.